Cerecolin Injections (250mg & 500mg) - Neuroprotective & Cognitive Recovery Therapy

Product Overview

Cerecolin Injection is a high-potency neuroprotective and cognitive-enhancing parenteral formulation containing Citicoline. Engineered for immediate systemic bioavailability via Intravenous (IV) or Intramuscular (IM) administration, Cerecolin is indicated for the clinical management of acute ischemic stroke, traumatic brain injury (TBI), vascular dementia, and age-related neurodegenerative disorders. Available in 250mg and 500mg strengths, Cerecolin works by repairing damaged neuronal cell membranes, limiting tissue necrosis, and boosting central neurotransmitter synthesis to accelerate neurological rehabilitation and motor recovery.

Key Benefits

\n
• \n

  Accelerates Neurological Recovery: Promotes faster rehabilitation and motor function recovery following acute ischemic stroke or head trauma.

  \n
\n
• \n

  Membrane Repair & Neuroprotection: Restores damaged neuronal phospholipid membranes and prevents enzymatic degradation of brain tissue.

  \n
\n
• \n

  Enhances Cognitive & Memory Function: Improves mental clarity, concentration, and memory retention in cognitive impairment and vascular dementia.

  \n
\n
• \n

  Boosts Neurotransmitter Synthesis: Elevates acetylcholine and dopamine levels in central neural pathways to support cognitive processing.

  \n
\n
• \n

  Immediate Parenteral Action: Rapid IV/IM delivery provides fast therapeutic blood levels during critical neurovascular emergencies.

  \n
\n

How It Works

Cerecolin Injection (Citicoline) functions as an essential intermediate in the biosynthesis of structural neuronal membrane phospholipids, primarily phosphatidylcholine. Following administration, it hydrolyzes into cytidine and choline, which cross the blood-brain barrier. Within brain tissue, it stabilizes neuronal membranes, inhibits the activation of phospholipase enzymes that trigger cell death, and suppresses free radical formation. Concurrently, it serves as a direct precursor for acetylcholine, restoring cholinergic transmission and repairing disrupted neural networks.

WooCommerce Attribute / Variation Details

Variation 1: CERECOLIN INJECTION 250MG

\n
• \n

  SKU: CER-INJ-250

  \n
\n
• \n

  Short Description: Lower-strength parenteral dose suitable for step-down maintenance therapy, pediatric/elderly dosage adjustments, or mild cognitive impairment protocols.

  \n
\n
• \n

  Key Active Ingredient: Citicoline Sodium — 250mg per ampoule/vial.

  \n
\n
• \n

  Target Indications: Mild-to-moderate cognitive decline, post-stroke recovery maintenance, and localized head trauma rehabilitation.

  \n
\n
• \n

  Standard Dosing: 250mg administered via slow IV or IM injection 1 to 2 times daily, or as directed by an attending physician.

  \n
\n

Variation 2: CERECOLIN INJECTION 500MG

\n
• \n

  SKU: CER-INJ-500

  \n
\n
• \n

  Short Description: High-potency acute care dose designed for acute ischemic stroke management, severe traumatic brain injury (TBI), and advanced neurovascular crisis protocols.

  \n
\n
• \n

  Key Active Ingredient: Citicoline Sodium — 500mg per ampoule/vial.

  \n
\n
• \n

  Target Indications: Acute phase of ischemic stroke, severe head injuries, acute vascular encephalopathy, and marked cognitive deficits.

  \n
\n
• \n

  Standard Dosing: 500mg to 1000mg daily administered via slow IV injection/infusion or deep IM injection under strict clinical supervision.

  \n
\n

General Product Details (Shared across variations)

Key Active Ingredients

\n
• \n

  Citicoline Sodium (250mg / 500mg per ampoule/vial): Central neuroprotective agent that rebuilds neuronal membrane phospholipids, mitigates cellular oxidative stress, and supports central acetylcholine synthesis.

  \n
\n

Directions for Use

\n
1. \n

   Administration: For Intravenous (IV) slow injection/infusion or deep Intramuscular (IM) injection only.

   \n
\n
2. \n

   Clinical Protocol: Select the appropriate strength (250mg or 500mg) based on the attending neurologist's prescription and acute/chronic clinical severity.

   \n
\n
3. \n

   Administration Rate: IV injections must be given slowly over 3 to 5 minutes (or diluted in compatible IV infusion solutions) to minimize the risk of transient hypotension.

   \n
\n
4. \n

   Professional Use Only: Must be administered by a qualified healthcare professional in a clinic or hospital environment.

   \n
\n

Precautions

\n
• \n

  Prescription-Only: Parenteral drug product; strictly prohibited for self-administration.

  \n
\n
• \n

  Hypertonia Warning: Exercise caution in patients with severe parasympathetic hypertonia.

  \n
\n
• \n

  Intracranial Hemorrhage: In cases of persistent intracranial hemorrhage, do not exceed 1000mg daily in single doses and administer very slowly.

  \n
\n
• \n

  Pregnancy & Lactation: Use only if the potential therapeutic benefit strictly outweighs potential fetal/infant risks under physician supervision.

  \n
\n
• \n

  Keep out of reach of children.

  \n
\n

Storage Instructions

Store in a cool, dry place below 30°C. Protect from direct light, excessive heat, and freezing. Use immediately once the ampoule or vial is opened; discard any unused portion.

Manufacturer Information

Formulated and manufactured in strict compliance with international pharmaceutical quality standards, committed to engineering advanced neurovascular and critical care injectable therapies that support brain health and clinical recovery.